VolitionRx (VNRX) stock jumped 70% in pre-market after achieving 99% pure tumor DNA isolation and detecting 49/49 cancers in a blind study.
Four-way collaboration brings together world-leading AI and biological expertise to make AI-predicted protein complex structures openly available to the global scientific community.
Proteomics service providers offer outsourced access to advanced protein analysis technologies, including mass spectrometry ...
This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...
A new collaboration between EMBL's European Bioinformatics Institute (EMBL-EBI), Google DeepMind, NVIDIA, and Seoul National University has made millions of AI-predicted protein complex structures ...
Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...
Four-way collaboration brings together world-leading AI and biological expertise to make AI-predicted protein complex structures openly available to ...
Morning Overview on MSN
New tool automates key steps in genome sequencing analysis
A Snakemake-based pipeline called Pipeasm automates key steps of genome assembly, from raw read trimming through scaffolding and contamination screening, and the authors report up to 99.6% BUSCO ...
Computational biology and bioinformatics is an interdisciplinary field that develops and applies computational methods to analyse large collections of biological data, such as genetic sequences, cell ...
Asianet Newsable on MSN
Why VNRX Stock Is Soaring Over 70% In Pre-Market Today?
The company said it can isolate nearly pure tumor DNA from blood, which potentially solves a key bottleneck in liquid biopsy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results